Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Subscribe here
Manage your subscriptions
Search
Facebook
Linkedin
Mail
Twitter
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Subscribe here
Manage your subscriptions
Tag: novartis
Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors
26th June 2017
Novartis has announced topline results from the global Phase III CANTOS study investigating the effi...